Immune modulation and stereotactic radiation: Improving local and abscopal responses

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Zeng, Jing ^a   Harris, Timothy J ^b   Lim, Michael ^b,c   Drake, Charles G ^b,c   Tran, Phuoc T ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; IMMUNOMODULATING AGENT; INTERLEUKIN 2; IPILIMUMAB; MONOCLONAL ANTIBODY; PD1 ANTIBODY; PROSTATE SPECIFIC ANTIGEN; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER CONTROL; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER MODEL; CANCER RADIOTHERAPY; CASTRATION RESISTANT PROSTATE CANCER; CELLULAR IMMUNITY; CYTOKINE RESPONSE; DRUG MEGADOSE; GLIOMA; HUMAN; IMMUNOMODULATION; KIDNEY CARCINOMA; LOW DRUG DOSE; METASTASIS; METASTATIC MELANOMA; MULTIMODALITY CANCER THERAPY; NONHUMAN; PARTIAL BODY RADIATION; PARTICLE RADIATION; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; REPEATED DRUG DOSE; REVIEW; STEREOTACTIC RADIATION; STEREOTACTIC RADIOSURGERY; THERAPY EFFECT; TRIPLE NEGATIVE BREAST CANCER; TUMOR CELL DESTRUCTION; TUMOR IMMUNITY; WHOLE BODY RADIATION; IMMUNOLOGY; IMMUNOTHERAPY; NEOPLASM; PATHOLOGY; RADIOSURGERY;

COMBINED MODALITY THERAPY; HUMANS; IMMUNOTHERAPY; NEOPLASMS; RADIATION DOSAGE; RADIOSURGERY;

EID: 84890043404     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/658126     Document Type: Review

References (42)

1. Dunn G. P., Bruce A. T., Ikeda H., Old L. J., Schreiber R. D., Cancer immunoediting: from immunosurveillance to tumor escape. Nature Immunology 2002 3 11 991 998 2-s2.0-0036852241 10.1038/ni1102-991 (Pubitemid 35363648)
2. Schreiber R. D., Old L. J., Smyth M. J., Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011 331 6024 1565 1570 2-s2.0-79953151458 10.1126/science.1203486
3. Matzinger P., Tolerance, danger, and the extended family. Annual Review of Immunology 1994 12 991 1045 2-s2.0-0028201732 (Pubitemid 24140436)
4. Street S. E. A., Cretney E., Smyth M. J., Perforin and interferon- γ activities independently control tumor initiation, growth, and metastasis. Blood 2001 97 1 192 197 2-s2.0-0035165729 10.1182/blood.V97.1.192 (Pubitemid 32061260)
5. Pulaski B. A., Smyth M. J., Ostrand-Rosenberg S., Interferon- γ -dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma. Cancer Research 2002 62 15 4406 4412 2-s2.0-0036681991 (Pubitemid 34827300)
6. Luft T., Pang K. C., Thomas E., Hertzog P., Hart D. N. J., Trapani J., Cebon J., Type I IFNs enhance the terminal differentiation of dendritic cells. Journal of Immunology 1998 161 4 1947 1953 2-s2.0-0032529213 (Pubitemid 28387618)
7. Sims G. P., Rowe D. C., Rietdijk S. T., Herbst R., Coyle A. J., HMGB1 and RAGE in inflammation and cancer. Annual Review of Immunology 2010 28 367 388 2-s2.0-77952298772 10.1146/annurev.immunol.021908.132603
8. Dunn G. P., Old L. J., Schreiber R. D., The three Es of cancer immunoediting. Annual Review of Immunology 2004 22 329 360 2-s2.0-2542430341 10.1146/annurev.immunol.22.012703.104803 (Pubitemid 38680426)
9. Zou W., Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature Reviews Cancer 2005 5 4 263 274 2-s2.0-16844379997 10.1038/nrc1586 (Pubitemid 40488632)
10. Drake C. G., Combination immunotherapy approaches. Annals of Oncology 2012 23, supplement 8 41 46
11. Hill-Kayser C. E., Plastaras J. P., Tochner Z., Glatstein E., TBI during BM and SCT: review of the past, discussion of the present and consideration of future directions. Bone Marrow Transplantation 2011 46 4 475 484 2-s2.0-79953698717 10.1038/bmt.2010.280
12. Campian J. L., Ye X., Brock M., Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer. Cancer Investigation 2013 31 3 183 188 10.3109/07357907.2013.767342
13. Harisiadis L., Kopelson G., Chang C. H., Lymphopenia caused by cranial irradiation in children receiving craniospinal radiotherapy. Cancer 1977 40 3 1102 1108 2-s2.0-0017657832 (Pubitemid 8219462)
14. Yovino S., Kleinberg L., Grossman S. A., Narayanan M., Ford E., The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells. Cancer Investigation 2013 31 2 140 144 10.3109/07357907.2012.762780
15. Demaria S., Formenti S. C., Sensors of ionizing radiation effects on the immunological microenvironment of cancer. International Journal of Radiation Biology 2007 83 11-12 819 825 2-s2.0-36849031260 10.1080/09553000701481816 (Pubitemid 350219096)
16. Melcher A., Todryk S., Hardwick N., Ford M., Jacobson M., Vile R. G., Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nature Medicine 1998 4 5 581 587 2-s2.0-0031836938 10.1038/nm0598-581 (Pubitemid 28237357)
17. Obeid M., Tesniere A., Ghiringhelli F., Fimia G. M., Apetoh L., Perfettini J.-L., Castedo M., Mignot G., Panaretakis T., Casares N., Métivier D., Larochette N., Van Endert P., Ciccosanti F., Piacentini M., Zitvogel L., Kroemer G., Calreticulin exposure dictates the immunogenicity of cancer cell death. Nature Medicine 2007 13 1 54 61 2-s2.0-33846057130 10.1038/nm1523 (Pubitemid 46067386)
18. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., Mignot G., Maiuri M. C., Ullrich E., Saulnier P., Yang H., Amigorena S., Ryffel B., Barrat F. J., Saftig P., Levi F., Lidereau R., Nogues C., Mira J.-P., Chompret A., Joulin V., Clavel-Chapelon F., Bourhis J., André F., Delaloge S., Tursz T., Kroemer G., Zitvogel L., Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature Medicine 2007 13 9 1050 1059 2-s2.0-34948820602 10.1038/nm1622 (Pubitemid 47517504)
19. Demaria S., Santori F. R., Ng B., Liebes L., Formenti S. C., Vukmanovic S., Select forms of tumor cell apoptosis induce dendritic cell maturation. Journal of Leukocyte Biology 2005 77 3 361 368 2-s2.0-14244262560 10.1189/jlb.0804478 (Pubitemid 40289566)
20. Formenti S. C., Demaria S., Radiation therapy to convert the tumor into an in situ vaccine. International Journal of Radiation Oncology. Biology. Physics 84 4 879 880
21. Reits E. A., Hodge J. W., Herberts C. A., Groothuis T. A., Chakraborty M., Wansley E. K., Camphausen K., Luiten R. M., De Ru A. H., Neijssen J., Griekspoor A., Mesman E., Verreck F. A., Spits H., Schlom J., Van Veelen P., Neefjes J. J., Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. Journal of Experimental Medicine 2006 203 5 1259 1271 2-s2.0-33646704729 10.1084/jem.20052494
22. Garnett C. T., Palena C., Chakarborty M., Tsang K.-Y., Schlom J., Hodge J. W., Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Research 2004 64 21 7985 7994 2-s2.0-7444258053 10.1158/0008-5472.CAN-04-1525 (Pubitemid 39446933)
23. Chakraborty M., Abrams S. I., Camphausen K., Liu K., Scott T., Coleman C. N., Hodge J. W., Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. Journal of Immunology 2003 170 12 6338 6347 2-s2.0-0037942745 (Pubitemid 36682620)
24. Demaria S., Ng B., Devitt M. L., Babb J. S., Kawashima N., Liebes L., Formenti S. C., Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. International Journal of Radiation Oncology Biology Physics 2004 58 3 862 870 2-s2.0-1242315588 10.1016/j.ijrobp.2003.09.012 (Pubitemid 38221143)
25. Zeng J., See A. P., Phallen J., Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. International Journal of Radiation Oncology Biology Physics 2013 86 2 343 349 10.1016/j.ijrobp.2012.12.025
26. Dewan M. Z., Galloway A. E., Kawashima N., Dewyngaert J. K., Babb J. S., Formenti S. C., Demaria S., Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clinical Cancer Research 2009 15 17 5379 5388 2-s2.0-69949085196 10.1158/1078-0432.CCR-09-0265
27. Demaria S., Kawashima N., Yang A. M., Devitt M. L., Babb J. S., Allison J. P., Formenti S. C., Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clinical Cancer Research 2005 11 2 I 728 734 2-s2.0-12244252335 (Pubitemid 40116901)
28. Verbrugge I., Hagekyriakou J., Sharp L. L., Radiotherapy increases the permissiveness of established mammary tumors to rejecton by immunomodulatory antibodies. Cancer Research 2012 72 13 3163 3174 10.1158/0008-5472.CAN-12-0210
29. Younes E., Haas G. P., Dezso B., Ali E., Maughan R. L., Kukuruga M. A., Montecillo E., Pontes J. E., Hillman G. G., Local tumor irradiation augments the response to IL-2 therapy in a murine renal adenocarcinoma. Cellular Immunology 1995 165 2 243 251 2-s2.0-0028867090 10.1006/cimm.1995.1211
30. Harris T. J., Hipkiss E. L., Borzillary S., Wada S., Grosso J. F., Yen H.-R., Getnet D., Bruno T. C., Goldberg M. V., Pardoll D. M., DeWeese T. L., Drake C. G., Radiotherapy augments the immune response to prostate cancer in a time-dependent manner. Prostate 2008 68 12 1319 1329 2-s2.0-50249112254 10.1002/pros.20794
31. Gulley J. L., Arlen P. M., Bastian A., Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer. Clinical Cancer Research 2005 11 9 3353 3362 2-s2.0-31544437216 10.1158/1078-0432.CCR-12-1-COR (Pubitemid 40627887)
32. Chi K.-H., Liu S.-J., Li C.-P., Kuo H.-P., Wang Y.-S., Chao Y., Hsieh S.-L., Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma. Journal of Immunotherapy 2005 28 2 129 135 2-s2.0-14744275172 (Pubitemid 40328199)
33. Kim Y. H., Gratzinger D., Harrison C., Brody J. D., Czerwinski D. K., Ai W. Z., Morales A., Abdulla F., Xing L., Navi D., Tibshirani R. J., Advani R. H., Lingala B., Shah S., Hoppe R. T., Levy R., In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study. Blood 2012 119 2 355 363 2-s2.0-84855832128 10.1182/blood-2011-05-355222
34. Seung S. K., Curti B. D., Crittenden M., Phase 1 study of stereotactic body radiotherapy and interleukin-2-tumor and immunological responses. Science Translational Medicine 4 137 137ra74
35. Postow M. A., Callahan M. K., Barker C. A., Yamada Y., Yuan J., Kitano S., Mu Z., Rasalan T., Adamow M., Ritter E., Sedrak C., Jungbluth A. A., Chua R., Yang A. S., Roman R.-A., Rosner S., Benson B., Allison J. P., Lesokhin A. M., Gnjatic S., Wolchok J. D., Immunologic correlates of the abscopal effect in a patient with melanoma. New England Journal of Medicine 2012 366 10 925 931 2-s2.0-84857815877 10.1056/NEJMoa1112824
36. Hiniker S. M., Chen D. S., Reddy S., A systemic complete response of metastatic melanoma to local radiation and immunotherapy. Translational Oncology 2012 5 6 404 407
37. Slovin S. F., Higano C. S., Hamid O., Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study. Annals of Oncology 2013 24 7 1813 1821
38. Schaue D., Ratikan J. A., Iwamoto K. S., McBride W. H., Maximizing tumor immunity with fractionated radiation. International Journal of Radiation Oncology Biology Physics 2012 83 4 1306 1310
39. Lee Y., Auh S. L., Wang Y., Burnette B., Wang Y., Meng Y., Beckett M., Sharma R., Chin R., Tu T., Weichselbaum R. R., Fu Y.-X., Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 2009 114 3 589 595 2-s2.0-70149113060 10.1182/blood-2009-02-206870
40. Demaria S., Formenti S. C., Radiation as an immunological adjuvant: current evidence on dose and fractionation. Frontiers in Oncology 2012 2 153
41. Ahmad S. S., Advances in radiotherapy. British Medical Journal 2012 345 e7765
42. Rong Y., Welsh J., Basics of particle therapy II biologic and dosimetric aspects of clinical Hadron therapy. American Journal of Clinical Oncology 2010 33 6 646 649 2-s2.0-78650026023 10.1097/COC.0b013e3181cdf0fe